Obesity-related liver conditions: Understanding treatment options
The prevalence of obesity has more than doubled since 1990, with nearly one billion people living with obesity globally in…
The prevalence of obesity has more than doubled since 1990, with nearly one billion people living with obesity globally in…
Ensuring the integrity of pharmaceutical products is one of the most complex challenges in global healthcare today. From temperature-sensitive biologics…
The pharmaceutical industry is in the midst of a digital revolution; technology investments and data-driven decision-making are constantly on the…
The field of central nervous system (CNS) drug development is awash with activity. Data from GlobalData’s drugs database, as of…
The pharmaceutical world is changing. Sales of personalised therapies, for example, will skyrocket from $8 billion in 2022 to a…
With 2025 well underway, the runaway momentum of artificial intelligence (AI) looks unstoppable. GlobalData estimates that the total AI market…
Immunotherapeutics have transformed the landscape of cancer outcomes. It is crucial that the atypical response patterns seen with them are…
Times are tough in the biopharmaceutical industry. Challenges including regulatory hurdles, supply chain fragility, geopolitical tensions and macroeconomic pressures are…
Precision medicine represents a new frontier in healthcare. By stratifying patients based on genomic and phenotypic variations, it addresses the…
The oncology market, already huge, is set for major expansion. According to analysis from GlobalData, it will generate trillions of…